Product
Recombinant Mycobacterium Tuberculosis Fusion Protein
Aliases
Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC)
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
Phase I Clinical Trial to Evaluate the Safety and Tolerability of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2023-05-09